title: [Emergent drugs (II): the Pharming phenomenon].
abstract: The use of medicines, with or without medical prescription, for recreational ends by the young population has received little attention from doctors. In the USA, one in five adolescents has used medicines for recreational purposes, and consultations in Emergency Departments for medicine abuse have exceeded those for illegal drugs. Although few data are available in Spain, such consumption is situated between 3.1 and 8.6% according to surveys. The medicines most used are dextromethorphan and methylphenidate. The former, on sale without prescription, presents a varied symptomatology, dosage and dependent metabolic action, ranging from euphoria to hallucinations. Methylphenidate, taken orally, nasally or intravenously, is used as a stimulant in substitution for cocaine and is one of the medicines most diverted onto the illicit market at the world level. In principle, other substances like modafinil and propofol present a limited incidence of non-medical use, but they have a probable abuse potential that should be borne in mind, above all in the health context. Finally, opiates like fentanyl, oxycodone and buprenorphine, with new pharmaceutical presentations, have recently become generalized in the therapeutic arsenal of many medical specialities; they are giving rise to phenomena of abuse, dependence and diversion towards the illicit market. Demands for detoxification treatment, their mixture with illegal substances, and cases of death should alert us to the abuse of these medicines.
authors: Universidad Europea de Canarias, Facultad de Ciencias de Salud, Servicio de Urgencias, Hospital Universitario de Canarias, Tenerife, España. gburillo@telefonica.net
authors: G
authors: G
authors: Burillo-Putze
authors: A
authors: A
authors: Aldea-Perona
authors: C
authors: C
authors: Rodríguez-Jiménez
authors: M M
authors: MM
authors: García-Sáiz
authors: B
authors: B
authors: Climent
authors: A
authors: A
authors: Dueñas
authors: P
authors: P
authors: Munné
authors: S
authors: S
authors: Nogué
authors: R S
authors: RS
authors: Hoffman
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D001559:Benzhydryl Compounds / Q000009:adverse effects; D003915:Dextromethorphan / Q000009:adverse effects; D006801:Humans; D013287:Illicit Drugs; D008774:Methylphenidate / Q000009:adverse effects; D000077408:Modafinil; D055553:Prescription Drugs; D015742:Propofol / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000453:epidemiology*
chemical_list: D000701:Analgesics, Opioid; D001559:Benzhydryl Compounds; D013287:Illicit Drugs; D055553:Prescription Drugs; D008774:Methylphenidate; D003915:Dextromethorphan; D000077408:Modafinil; D015742:Propofol